Filing Details

Accession Number:
0001005201-19-000045
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-03-18 08:01:51
Reporting Period:
2019-03-14
Accepted Time:
2019-03-18 08:01:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1005201 Assertio Therapeutics Inc ASRT Pharmaceutical Preparations (2834) 943229046
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1663041 Stan Bukofzer Assertio Therapeutics, Inc.
100 South Saunders Road, Suite 300
Lake Forest IL 60045
Svp, Chf Scitfc & Tech Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-03-14 5,000 $4.13 5,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported is a weighted average purchase price. The shares were purchased in multiple same-way transactions on March 14, 2019 at prices ranging from $4.123 to $4.133 per share of common stock. If requested by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, the reporting person will provide full information regarding the number of shares of common stock purchased at each separate price.